Argenica Therapeutics Ltd
ASX:AGN

Watchlist Manager
Argenica Therapeutics Ltd Logo
Argenica Therapeutics Ltd
ASX:AGN
Watchlist
Price: 0.68 AUD -3.55% Market Closed
Market Cap: 87.1m AUD

Argenica Therapeutics Ltd
Investor Relations

Argenica Therapeutics Ltd. provides neuroprotective treatment. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2021-06-11. Argenica’s lead candidate, ARG-007, aims to protect brain cells and reduce cell death following a stroke, and other types of neural injury. Argenica has accumulated a comprehensive body of published pre-clinical studies demonstrating efficacy of ARG-007 in multiple models of stroke and other central nervous system injury models, including stroke, traumatic brain injury and perinatal hypoxia ischaemia.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Dr. Liz Dallimore B.Sc., M.B.A., Ph.D.
CEO, MD & Director
No Bio Available
Ms. Emma Waldon
CFO & Company Secretary
No Bio Available
Prof. Bruno Philip Meloni
Chief Scientific Officer
No Bio Available

Contacts

Address
WESTERN AUSTRALIA
Nedlands
4/117 Broadway
Contacts
+893293396.0
argenica.com.au